Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling
Daniel J. Perry(University of Florida), Todd M. Brusko(University of Florida), MacKenzie D. Williams(Florida College), Mark A. Wallet(Florida College), Andrew Muir(Children's Medical Center), Desmond Schatz(University of Florida), Michael J. Haller(University of Florida), Mark A. Atkinson(University of Florida), Clayton E. Mathews(University of Florida), Amanda L. Posgai(University of Florida), Clive Wasserfall(University of Florida), Richard A. Oram(University of Exeter)
Cited by 84
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k